HOXA1
Basic information
Region (hg38): 7:27092993-27096000
Previous symbols: [ "HOX1F", "HOX1" ]
Links
Phenotypes
GenCC
Source:
- human HOXA1 syndromes (Definitive), mode of inheritance: AR
- human HOXA1 syndromes (Moderate), mode of inheritance: AR
- Bosley-Salih-Alorainy syndrome (Supportive), mode of inheritance: AR
- human HOXA1 syndromes (Supportive), mode of inheritance: AR
- human HOXA1 syndromes (Strong), mode of inheritance: AR
- syndromic intellectual disability (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Athabaskan brainstem dysgenesis syndrome; Bosley-Salih-Alorainy syndrome | AR | Audiologic/Otolaryngologic; Cardiovascular | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; The conditions can involve congenital cardiac anomalies, and awareness may allow early management | Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Neurologic | 16155570; 18412118; 20075099 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (73 variants)
- Bosley-Salih-Alorainy_syndrome (20 variants)
- not_provided (19 variants)
- Human_HOXA1_syndromes (13 variants)
- HOXA1-related_disorder (7 variants)
- not_specified (3 variants)
- Intellectual_disability (3 variants)
- Bilateral_microtia-deafness-cleft_palate_syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOXA1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005522.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 22 | ||||
missense | 61 | 65 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 4 | 1 | 69 | 17 | 1 |
Highest pathogenic variant AF is 0.00000657255
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HOXA1 | protein_coding | protein_coding | ENST00000343060 | 2 | 3004 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.285 | 0.711 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.103 | 196 | 192 | 1.02 | 0.0000105 | 2178 |
Missense in Polyphen | 102 | 98.188 | 1.0388 | 1152 | ||
Synonymous | -0.732 | 93 | 84.4 | 1.10 | 0.00000516 | 686 |
Loss of Function | 2.46 | 3 | 12.3 | 0.243 | 5.97e-7 | 134 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000530 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific transcription factor (By similarity). Regulates multiple developmental processes including brainstem, inner and outer ear, abducens nerve and cardiovascular development and morphogenesis as well as cognition and behavior (PubMed:16155570). Also part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Acts on the anterior body structures. Seems to act in the maintenance and/or generation of hindbrain segments (By similarity). Activates transcription in the presence of PBX1A and PKNOX1 (By similarity). {ECO:0000250|UniProtKB:P09022, ECO:0000250|UniProtKB:Q90423, ECO:0000269|PubMed:16155570}.;
- Disease
- DISEASE: Athabaskan brainstem dysgenesis syndrome (ABDS) [MIM:601536]: Characterized by horizontal gaze palsy, sensorineural deafness, central hypoventilation, and developmental delay. Some patients had swallowing dysfunction, vocal cord paralysis, facial paresis, seizures, and cardiac outflow tract anomalies. {ECO:0000269|PubMed:16155570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bosley-Salih-Alorainy syndrome (BSAS) [MIM:601536]: A disease characterized by horizontal gaze abnormalities, deafness, facial weakness, vascular malformations of the internal carotid arteries and cardiac outflow trac. Some patients manifest mental retardation and autism spectrum disorder. Affected individuals do not suffer from central hypoventilation. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Neural Crest Differentiation;Endoderm Differentiation;Activation of anterior HOX genes in hindbrain development during early embryogenesis
(Consensus)
Recessive Scores
- pRec
- 0.229
Intolerance Scores
- loftool
- 0.215
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.74
Haploinsufficiency Scores
- pHI
- 0.803
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.962
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hoxa1
- Phenotype
- digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- multicellular organism development;sensory perception of sound;optokinetic behavior;anatomical structure morphogenesis;abducens nerve formation;outer ear morphogenesis;positive regulation of transcription by RNA polymerase II;embryonic neurocranium morphogenesis;inner ear development;artery morphogenesis;regulation of behavior;cognition;neuromuscular process;artery development;semicircular canal formation;cochlea development;cochlea morphogenesis
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding;identical protein binding;sequence-specific DNA binding